Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 21,146 | 23,795 | 19,552 | 21,762 | 20,222 |
| Cost of Goods | 9,838 | 12,413 | 10,068 | 11,134 | 9,173 |
| Gross Profit | 11,308 | 11,382 | 9,484 | 10,628 | 11,049 |
| Operating Expenses | 24,642 | 36,439 | 42,490 | 36,459 | 38,192 |
| Operating Income | -12,496 | -24,644 | -32,938 | -25,697 | -26,970 |
| Interest Expense | 0 | 7 | 10 | 9 | 0 |
| Other Income | -2,119 | 2,620 | 48 | 7,424 | 3,481 |
| Pre-tax Income | -14,615 | -22,031 | -32,900 | -18,282 | -23,489 |
| Income Tax | 11 | -35,932 | -1,216 | -609 | -119 |
| Net Income Continuous | -14,626 | 13,901 | -31,684 | -17,673 | -23,370 |
| Net Income Discontinuous | 141,694 | 5,382 | -3,003 | -15,786 | -2,663 |
| Net Income | $127,068 | $19,283 | $-34,687 | $-33,459 | $-26,033 |
| EPS Basic Total Ops | 0.33 | 0.05 | -0.09 | -0.09 | -0.07 |
| EPS Basic Continuous Ops | -0.04 | 0.04 | -0.08 | -0.05 | -0.06 |
| EPS Basic Discontinuous Ops | 0.37 | 0.02 | -0.01 | -0.04 | -0.01 |
| EPS Diluted Total Ops | 0.33 | 0.05 | -0.09 | -0.09 | -0.07 |
| EPS Diluted Continuous Ops | -0.04 | 0.04 | -0.08 | -0.05 | -0.06 |
| EPS Diluted Discontinuous Ops | 0.37 | 0.02 | -0.01 | -0.04 | -0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.05 | -0.06 | -0.05 | -0.06 |
| EBITDA(a) | $-11,720 | $-23,815 | $-32,028 | $-22,433 | $-23,640 |